Boehringer Ingelheim Wins EU Approval for JASCAYD
INGELHEIM, Germany, July 17, 2026 Boehringer Ingelheim has announced that the European Commission (EC) has granted marketing authorization for...
Prescription, Generic, and Over-The-Counter: Drugs & Products.
Merck Wins FDA Approval for Oral PCSK9 Drug LIPFENDRA
RAHWAY, N.J., July 16, 2026 Merck has achieved a significant milestone in cardiovascular medicine with the U.S. Food and...
Orasis Files Australia NDA for BESKA Eye Drops
PONTE VEDRA, Fla., July 15, 2026 Orasis Pharmaceuticals has reached an important international regulatory milestone with the submission of...
Genentech Wins FDA Priority Review for Gazyva in pMN
SOUTH SAN FRANCISCO, Calif., July 14, 2026 Genentech, a member of the Roche Group, has received U.S. Food and...
Novo Nordisk Secures EU Approval for Oral Wegovy
BAGSVÆRD, Denmark, July 15, 2026 Novo Nordisk has achieved a major regulatory milestone after the European Commission (EC) granted...
Merck’s KEYTRUDA Tops Chemo in dMMR Endometrial Cancer
RAHWAY, N.J., July 15, 2026 Merck has announced that its blockbuster PD-1 inhibitor KEYTRUDA® (pembrolizumab) achieved the primary endpoint...
MAXONA Wins FDA IND Clearance for MAX-001 Phase 2 Trial
MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...
Celcuity Wins FDA Approval for REVTORPYK in Breast Cancer
MINNEAPOLIS, Minn., July 14, 2026 Celcuity Inc. has achieved a major regulatory milestone after the U.S. Food and Drug...
Apnimed Targets First Oral Sleep Apnea Therapy with FDA NDA
CAMBRIDGE, Mass., July 14, 2026 Apnimed, Inc. has achieved a significant regulatory milestone after the U.S. Food and Drug...
Boehringer Reports Strong H1 2026 Sales
INGELHEIM, Germany, July 15, 2026 Boehringer Ingelheim reported strong financial and operational performance for the first half of 2026,...